2023
DOI: 10.3390/biomedicines11020257
|View full text |Cite
|
Sign up to set email alerts
|

Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity

Abstract: Recent studies provide some evidence for the contribution of antibody-mediated autoimmune mechanisms to the nature of fibromyalgia (FM) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Much attention was paid to the autoantibodies (AAb) targeting G protein-coupled receptors as natural components of the immune system. However, the natural AAb network is much more extensive, and has not been previously investigated in these disorders. The enzyme immunoassays ELI-Viscero-Test and ELI-Neuro-Test we… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 40 publications
0
4
0
Order By: Relevance
“…Interestingly, Long COVID patients also have reported other dysfunctions, which previously were associated with, including neurologic pain, neurocognitive and psychiatric symptoms, however with no cases of rash, as well as olfactory and gustatory dysfunction [11] (Figure 1). Although the exact aetiology of ME/CFS, neither Long COVID still needs to be determined, evidence to date indicate as post-viral syndromes, being most likely triggered by the infectious agent, such as Epstein Barr Virus [12] and SARS-CoV-2 in Long COVID [13], respectively, also share biological abnormalities, with examples of the cognitive deficits, including impaired attention and information processing speed, dysregulation of the hypothalamic-pituitary (HP) axis, and abnormal immune cytokine profile [14], characterized by high auto-antibodies titres against neural and autonomic targets [15,16] including neurotransmitter receptors against nuclear and membrane structures, such as cardiopin and phospholipids, neurotransmitter receptors (e.g., muscarinic M1 acetylcholine receptor (AChR) and ß1-and ß2-adrenergic receptors (AdR) and M2/3 [17]); as well as and increased levels of proinflammatory mediators, interleukin (IL) IL-1 (IL-1α, IL-1β), IL-4, IL-5, IL-6, and IL-12, TNF-α, IL-10, IL-13, IL-16, INF-γ, and IL-17, IL-17A (but reduced IL-17F) [18][19][20], further linked with severity of after mentioned symptoms [21]. In particularly, metabolic abnormalities along with mitochondrial dysfunction and impaired redox balance [22] characterized by increased oxidative toxicity and lowered antioxidant defenses were associated with the development of symptoms of pain and hyper-sensitivity [23] and severity of neuropsychiatric symptoms in both ME/CFS [18] and Long COVID [24].…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, Long COVID patients also have reported other dysfunctions, which previously were associated with, including neurologic pain, neurocognitive and psychiatric symptoms, however with no cases of rash, as well as olfactory and gustatory dysfunction [11] (Figure 1). Although the exact aetiology of ME/CFS, neither Long COVID still needs to be determined, evidence to date indicate as post-viral syndromes, being most likely triggered by the infectious agent, such as Epstein Barr Virus [12] and SARS-CoV-2 in Long COVID [13], respectively, also share biological abnormalities, with examples of the cognitive deficits, including impaired attention and information processing speed, dysregulation of the hypothalamic-pituitary (HP) axis, and abnormal immune cytokine profile [14], characterized by high auto-antibodies titres against neural and autonomic targets [15,16] including neurotransmitter receptors against nuclear and membrane structures, such as cardiopin and phospholipids, neurotransmitter receptors (e.g., muscarinic M1 acetylcholine receptor (AChR) and ß1-and ß2-adrenergic receptors (AdR) and M2/3 [17]); as well as and increased levels of proinflammatory mediators, interleukin (IL) IL-1 (IL-1α, IL-1β), IL-4, IL-5, IL-6, and IL-12, TNF-α, IL-10, IL-13, IL-16, INF-γ, and IL-17, IL-17A (but reduced IL-17F) [18][19][20], further linked with severity of after mentioned symptoms [21]. In particularly, metabolic abnormalities along with mitochondrial dysfunction and impaired redox balance [22] characterized by increased oxidative toxicity and lowered antioxidant defenses were associated with the development of symptoms of pain and hyper-sensitivity [23] and severity of neuropsychiatric symptoms in both ME/CFS [18] and Long COVID [24].…”
Section: Introductionmentioning
confidence: 99%
“…FM is associated with oxidative stress and mitochondrial, immunological, and cardiovascular autonomic dysfunction [ 17 , 18 , 19 , 20 , 21 ]. Furthermore, recent hypotheses concerning its pathophysiology include the role of inflammation, gut dysbiosis, neuroinflammation, and DNA methylation [ 22 , 23 ].…”
Section: Introductionmentioning
confidence: 99%
“…Although the root cause(s) of PAIS remain unclear, a wealth of data supports an autoimmune etiology of PAIS 3,[14][15][16][17][18][19][20][21][22][23] . For example, AABs have been found in ME/CFS [24][25][26] , chronic Lyme disease 27,28 , and LC 3,[14][15][16][17][18][19][20][21][22][23] , some of which target GPCRs and GABA receptors involved in neuronal pathways relevant to neurological symptoms.…”
Section: Introductionmentioning
confidence: 99%